Key Highlights
- Eleanor Health raises $30 million in Series D financing led by General Catalyst.
- Funds will scale Eleanor’s whole-person care model for substance use disorder.
- Innovative value-based payment structures improving quality and reducing costs.
- Eleanor’s care model includes MAT, psychiatry, therapy, and peer recovery coaching.
Source: Business Wire
Notable Quotes
- “This funding represents a significant vote of confidence from our investors that our model works and our team is well positioned to scale that model across the country.” — William McKinney, CEO at Eleanor Health
- “Eleanor’s approach is a much-needed departure from many traditional recovery programs… We believe that Eleanor is transforming the quality, delivery, and accessibility of substance use disorder care.” — Chris Bischoff, Managing Director at General Catalyst
SoHC's Take
Eleanor Health’s successful Series D financing round is a testament to the growing need for innovative approaches in addiction treatment. Their value-based, whole-person care model offers a refreshing alternative to traditional fee-for-service systems, and the backing of prominent investors like General Catalyst signals confidence in the scalability and impact of their approach. By focusing on both clinical outcomes and cost reduction, Eleanor is poised to make a substantial impact on the treatment of substance use disorder across the United States.
